Channelchek - Looking for the next apple? This is the orchard.

ZOMDF

$0.09

(-3.45%)

FLWS

$4.21

(0.24%)

ACCO

$4.07

(1.24%)

ARLP

$24.91

(1.01%)

AUIAF

$0.15

(0%)

AZZ

$150.79

(0.25%)

BTBT

$1.56

(-1.27%)

BTM

$0.49

(0%)

CVKD

$2.1

(-3.23%)

LCE:CA

$0.25

(-5.66%)

COCP

$0.94

(0.66%)

CDRO

$9.18

(-1.08%)

CVGI

$4.77

(-2.25%)

LODE

$3.95

(-0.25%)

CMTL

$1.71

(-1.16%)

CNDT

$1.51

(-2.58%)

CXW

$32.18

(0.31%)

CMLS

$0.01

(0%)

DRCT

$2.67

(-0.74%)

DLHC

$5.13

(-5%)

SSP

$3.17

(-2.76%)

ELDN

$3.72

(-5.82%)

EVC

$10.45

(-3.69%)

EDRY

$24.74

(2.57%)

ESEA

$73.76

(1.11%)

FAT

$0.16

(0%)

RAIL

$8.16

(4.48%)

GDEV

(0%)

GOVX

$0.94

(-5.93%)

GOCO

$0.3

(0%)

GHM

$105.38

(-2.62%)

GLDD

$17

(0%)

GYRE

$7.58

(-1.88%)

HMENF

$1.89

(1.18%)

III

$3.94

(-1.25%)

IPOOF

$10.98

(3.29%)

KELYA

$15.4

(0.33%)

KTOS

$47.89

(-0.66%)

LUCK

$7.14

(-0.56%)

MAIA

$1.3

(-2.26%)

MGROF

$0.23

(-11.59%)

NTRB

$3.05

(-0.97%)

OCGN

$1.29

(-0.77%)

PERF

$1.92

(-0.52%)

QMCI

$0.15

(-0.66%)

RGP

$4.61

(-1.07%)

SGA

$8.54

(-2.79%)

SHWZ

(0%)

SHIP

$15.27

(0.26%)

SLQT

$0.72

(-3.63%)

SKYX

$1.32

(8.2%)

SNAL

$4.87

(-6.35%)

GEO

$31.34

(0.35%)

ODP

$28

(0%)

TNXP

$10.59

(-8.39%)

TSQ

$6.46

(-1.22%)

TZOO

$10.23

(-2.48%)

UNCY

$5.57

(-2.11%)

VVX

$81

(2.7%)

VNCE

$6.48

(-3.14%)

XELB

$1.36

(4.62%)

ZOMDF

$0.09

(-3.45%)

FLWS

$4.21

(0.24%)

channelchek-in

‌

7/22/2026

Repligen Pays $1.5 Billion for BioLife Solutions to Lock In Recurring Revenue in the Cell Therapy Boom

The life sciences tools sector produced another significant consolidation this week. Repligen Corporation (Nasdaq: RGEN), a bioprocessing technology company, announced Wednesday it has entered into a definitive agreement to acquire BioLife Solutions (Nasdaq: BLFS), a leading supplier of cell processing tools for the cell and gene therapy market, in a deal valued at approximately $1.5 billion in total enterprise value. The boards of both companies unanimously approved the transaction.

4 min read